Virtus ETF Advisers’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,954
Closed -$234K 505
2025
Q4
$234K Hold
12,954
0.11% 208
2025
Q3
$240K Hold
12,954
0.13% 194
2025
Q2
$207K Hold
12,954
0.13% 198
2025
Q1
$252K Buy
+12,954
New +$273K 0.16% 176

Other funds holding CLBT

Virtus ETF Advisers's CLBT Position: Q1 2026 in Review

Virtus ETF Advisers sold out of Cellebrite (CLBT) in Q1 2026, closing a stake of 12,954 shares — an estimated $234K sold.

Virtus ETF Advisers first reported a position in CLBT in Q1 2025 and held it in 4 quarters. The position peaked at $252K in Q1 2025. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Virtus ETF Advisers reported no remaining Cellebrite position as of Q1 2026 after selling out during the quarter.
  • Virtus ETF Advisers sold 12,954 Cellebrite shares in Q1 2026, an estimated $234K.
  • Virtus ETF Advisers first reported a position in Cellebrite in Q1 2025 and held it in 4 quarters.
  • Virtus ETF Advisers's Cellebrite position peaked at $252K in Q1 2025.
  • 221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Virtus ETF Advisers's 13F filing for Q1 2026, filed 14 May 2026.